A Study of XZB-0004 in Patients With Solid Tumors

NCT05772455 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
NSCLC

Interventions

DRUG: XZB-0004

Sponsor

Xuanzhu Biopharmaceutical Co., Ltd.